Results 51 to 60 of about 695,469 (357)

Assessment of pulmonary edema: principles and practice [PDF]

open access: yes, 2018
Pulmonary edema increasingly is recognized as a perioperative complication affecting outcome. Several risk factors have been identified, including those of cardiogenic origin, such as heart failure or excessive fluid administration, and those related to ...
Assaad, Sherif   +4 more
core   +1 more source

YouTube-videos for patient education in lymphangioleiomyomatosis?

open access: yesRespiratory Research, 2022
Background The Internet is commonly used by patients to acquire health information. To date, no studies have evaluated the quality of information available on YouTube regarding lymphangioleiomyomatosis (LAM).
Finn M. Wilkens   +7 more
doaj   +1 more source

Endothelial Cells Expressing Endothelial and Mesenchymal Cell Gene Products in Lung Tissue From Patients With Systemic Sclerosis-Associated Interstitial Lung Disease. [PDF]

open access: yes, 2016
OBJECTIVE: To examine whether lung endothelial cells (ECs) from patients with systemic sclerosis (SSc)-associated interstitial lung disease (ILD) express mesenchymal cell-specific proteins and gene transcripts, indicative of the occurrence of endothelial-
Arciniegas   +41 more
core   +2 more sources

Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis

open access: yesEuropean Respiratory Review, 2019
Two antifibrotic medications (nintedanib and pirfenidone) were recommended (conditionally) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) in the 2015 IPF evidence-based guidelines.
Bridget F. Collins, Ganesh Raghu
doaj   +1 more source

The incidence of malignancies in asbestosis with chrysotile exposure: a large Chinese prospective cohort study

open access: yesFrontiers in Oncology, 2023
BackgroundAsbestos exposure is closely related to the occurrence and development of various malignancies. This prospective cohort study aimed to evaluate the incidence rate and potential risk factors in a cohort of asbestosis patients in China.MethodsThe
Jingwei Wang   +7 more
doaj   +1 more source

Guanylyl cyclase activation reverses resistive breathing–induced lung injury and inflammation [PDF]

open access: yes, 2015
Inspiratory resistive breathing (RB), encountered in obstructive lung diseases, induces lung injury. The soluble guanylyl cyclase (sGC)/cyclic guanosine monophosphate (cGMP) pathway is down-regulated in chronic and acute animal models of RB, such as ...
Brouckaert, Peter   +15 more
core   +2 more sources

Prognosis and Follow-Up of Idiopathic Pulmonary Fibrosis

open access: yesMedical Sciences, 2018
Idiopathic pulmonary fibrosis (IPF), a devastating progressive interstitial lung disease (ILD) with no known cause, is the most common and deadly of the idiopathic interstitial pneumonias.
Estrella Fernández Fabrellas   +3 more
doaj   +1 more source

Small airway dysfunction in pneumoconiosis: a cross-sectional study

open access: yesBMC Pulmonary Medicine, 2022
Background Although several histological studies have documented airway inflammation and remodelling in the small airways of dust-exposed workers, little is known regarding the prevalence and risk factors of small airway dysfunction (SAD) in ...
Yali Fan   +5 more
doaj   +1 more source

Is the internet a sufficient source of information on sarcoidosis?

open access: yesFrontiers in Medicine, 2023
IntroductionMany patients use the internet as a source of health information. Sarcoidosis is a complex disease, and internet resources have not yet been analyzed for reliability and content on sarcoidosis.AimsOur study aimed to investigate the content ...
Katharina Buschulte   +11 more
doaj   +1 more source

Amiodarone-Induced Pulmonary Toxicity - A Frequently Missed Complication. [PDF]

open access: yes, 2016
IntroductionAmiodarone is often used in the suppression of tachyarrhythmias. One of the more serious adverse effects includes amiodarone pulmonary toxicity (APT).
Dang, Natasha   +4 more
core   +2 more sources

Home - About - Disclaimer - Privacy